product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
EpCAM/TROP1 Antibody (VU-1D9)
catalog :
NBP2-33051
quantity :
0.1 mg (also 0.02 mg)
price :
429 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
VU-1D9
reactivity :
human, rat
application :
western blot, immunohistochemistry, immunocytochemistry, flow cytometry, immunohistochemistry - paraffin section
more info or order :
citations: 21
Published Application/Species/Sample/DilutionReference
  • immunocytochemistry; human; fig 2a
Pailler E, Oulhen M, Billiot F, Galland A, Auger N, Faugeroux V, et al. Method for semi-automated microscopy of filtration-enriched circulating tumor cells. BMC Cancer. 2016;16:477 pubmed publisher
Papadaki M, Sotiriou A, Vasilopoulou C, Filika M, Aggouraki D, Tsoulfas P, et al. Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy. Cancers (Basel). 2020;12: pubmed publisher
Dang Z, Su S, Jin G, Nan X, Ma L, Li Z, et al. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat. J Ethnopharmacol. 2020;250:112470 pubmed publisher
Sukketsiri W, Hoshino K, Kugo H, Nakamura T, Sasoh T, Moriyama T, et al. Isoflavone Ameliorated Oxidative Stress and Vascular Damages in Nicotine-Administrated Mice. J Oleo Sci. 2019;68:1241-1249 pubmed publisher
Pailler E, Faugeroux V, Oulhen M, Mezquita L, Laporte M, Honoré A, et al. Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung Cancer. Clin Cancer Res. 2019;25:6671-6682 pubmed publisher
Su Y, Li H, Yan Z, Li M, Wei J, Zheng W, et al. Renin-angiotensin system activation and imbalance of matrix metalloproteinase-9/tissue inhibitor of matrix metalloproteinase-1 in cold-induced stroke. Life Sci. 2019;:116563 pubmed publisher
Bae E, Kim I, Choi H, Kim H, Kim C, Ma S, et al. Tumor necrosis factor α-converting enzyme inhibitor attenuates lipopolysaccharide-induced reactive oxygen species and mitogen-activated protein kinase expression in human renal proximal tubule epithelial cells. Korean J Physiol Pharmacol. 2018;22:135-143 pubmed publisher
Wang S, Asthana S, van Zante A, Heaton C, Phuchareon J, Stein L, et al. Establishment and characterization of an oral tongue squamous cell carcinoma cell line from a never-smoking patient. Oral Oncol. 2017;69:1-10 pubmed publisher
Watanabe R, Suzuki J, Wakayama K, Maejima Y, Shimamura M, Koriyama H, et al. A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction. Sci Rep. 2017;7:43920 pubmed publisher
Massard C, Oulhen M, Le Moulec S, Auger N, Foulon S, Abou Lovergne A, et al. Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study. Oncotarget. 2016;7:55069-55082 pubmed publisher
Kim C, Kim I, Bae E, Ma S, Lee J, Kim S. Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats. PLoS ONE. 2015;10:e0142664 pubmed publisher
Mori K, Noguchi M, Tobu S, Sato F, Mimata H, Tyagi P, et al. Age-related changes in bladder function with altered angiotensin II receptor mechanisms in rats. Neurourol Urodyn. 2016;35:908-913 pubmed publisher
Wang H, Wang J, Guo C, Luo W, Kleiman K, Eitzman D. Renal denervation attenuates progression of atherosclerosis in apolipoprotein E-deficient mice independent of blood pressure lowering. Hypertension. 2015;65:758-65 pubmed publisher
Jang H, Kim J, Kim J, Park J, Park K. Angiotensin II removes kidney resistance conferred by ischemic preconditioning. Biomed Res Int. 2014;2014:602149 pubmed publisher
Ma K, Ni J, Wang C, Liu J, Zhang Y, Wu Y, et al. Interaction of RAS activation and lipid disorders accelerates the progression of glomerulosclerosis. Int J Med Sci. 2013;10:1615-24 pubmed publisher
Li C, Li X, Shen Q, Li Y, He L, Li M, et al. Critical role of matrix metalloproteinase-9 in acute cold exposure-induced stroke in renovascular hypertensive rats. J Stroke Cerebrovasc Dis. 2013;22:e477-85 pubmed publisher
Ni J, Ma K, Wang C, Liu J, Zhang Y, Lv L, et al. Activation of renin-angiotensin system is involved in dyslipidemia-mediated renal injuries in apolipoprotein E knockout mice and HK-2 cells. Lipids Health Dis. 2013;12:49 pubmed publisher
Emmanuel C, Gava N, Kennedy C, Balleine R, Sharma R, Wain G, et al. Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis. PLoS ONE. 2011;6:e17617 pubmed publisher
Brunner A, Prelog M, Verdorfer I, Tzankov A, Mikuz G, Ensinger C. EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder. J Clin Pathol. 2008;61:307-10 pubmed
Winter M, Nagtegaal I, van Krieken J, Litvinov S. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol. 2003;163:2139-48 pubmed
Li G, Passebosc Faure K, Lambert C, Gentil Perret A, Blanc F, Oosterwijk E, et al. Flow cytometric analysis of antigen expression in malignant and normal renal cells. Anticancer Res. 2000;20:2773-8 pubmed
product information
master code :
NBP2-33051
SKU :
NBP2-33051
product name :
EpCAM/TROP1 Antibody (VU-1D9)
unit size :
0.1 mg (also 0.02 mg)
description :
The EpCAM/TROP1 Antibody (VU-1D9) from Novus is a mouse monoclonal antibody to EpCAM/TROP1. This antibody reacts with ferret (negative),human,rat,rat (negative). The EpCAM/TROP1 Antibody (VU-1D9) has been validated for the following applications: Flow Cytometry,Western Blot,Immunocytochemistry/ Immunofluorescence,Immunohistochemistry,Immunohistochemistry-Paraffin.
target :
EpCAM/TROP1
category :
Primary Antibodies
buffer :
10 mM PBS with 0.05% BSA
clonality :
Monoclonal
clone :
VU-1D9
concentration :
0.2 mg/ml
conjugate :
Unconjugated
host :
Mouse
immunogen :
Small cell lung carcinoma cells
isotype :
IgG1 Kappa
purity :
Protein A or G purified
species :
Ferret (Negative),Human,Rat,Rat (Negative)
specificity :
EGP40 is a 40-43kDa transmembrane epithelial glycoprotein, also identified as epithelial specific antigen (ESA), or epithelial cellular adhesion molecule (Ep-CAM)
gene symbol :
EPCAM
accessionNumbers :
P16422, P16422
applications :
Flow Cytometry,Western Blot,Immunocytochemistry/ Immunofluorescence,Immunohistochemistry,Immunohistochemistry-Paraffin
USD :
429 USD
alt names :
17-1A, 323/A3, ACSTD1, antigen identified by monoclonal AUA1, CD326 antigen, Cell surface glycoprotein Trop-1, chromosome 4, surface marker (35kD glycoprotein), DIAR5, EGP, EGP-2, EGP314, EGP40, EpCAM, epithelial cell adhesion molecule, Epithelial cell surface antigen, Epithelial glycoprotein, Epithelial glycoprotein 314, ESA, GA733-2EGP34, hEGP314, HNPCC8, KS 1/4 antigen, KS1/4, KSAHEA125, M1S2, M4S1Ly74, Major gastrointestinal tumor-associated protein GA733-2, MIC18MH99, MOC31, TACST-1, TACSTD1, TROP1CD326, Tumor-associated calcium signal transducer 1CO-17A
storage :
Store at 4C.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.